BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21741474)

  • 1. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.
    Cuperus R; van Kuilenburg AB; Leen R; Bras J; Caron HN; Tytgat GA
    Free Radic Biol Med; 2011 Sep; 51(6):1213-20. PubMed ID: 21741474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
    Yang B; Keshelava N; Anderson CP; Reynolds CP
    Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.
    Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB
    Int J Oncol; 2008 May; 32(5):1011-9. PubMed ID: 18425327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
    Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
    Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
    Anderson CP; Reynolds CP
    Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Park WH
    Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
    Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
    Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E, γ-tocotrienol, Protects Against Buthionine Sulfoximine-Induced Cell Death by Scavenging Free Radicals in SH-SY5Y Neuroblastoma Cells.
    Tan JK; Then SM; Mazlan M; Jamal R; Ngah WZ
    Nutr Cancer; 2016; 68(3):507-17. PubMed ID: 27008382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.
    Sun SY; Li W; Yue P; Lippman SM; Hong WK; Lotan R
    Cancer Res; 1999 May; 59(10):2493-8. PubMed ID: 10344763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
    Morales MC; Pérez-Yarza G; Nieto-Rementeria N; Boyano MD; Jangi M; Atencia R; Asumendi A
    Anticancer Res; 2005; 25(3B):1945-51. PubMed ID: 16158929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines.
    Anderson CP; Tsai J; Chan W; Park CK; Tian L; Lui RM; Forman HJ; Reynolds CP
    Eur J Cancer; 1997 Oct; 33(12):2016-9. PubMed ID: 9516845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma.
    Marengo B; De Ciucis C; Verzola D; Pistoia V; Raffaghello L; Patriarca S; Balbis E; Traverso N; Cottalasso D; Pronzato MA; Marinari UM; Domenicotti C
    Free Radic Biol Med; 2008 Feb; 44(3):474-82. PubMed ID: 17991446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Rac in fenretinide-induced apoptosis.
    Kadara H; Tahara E; Kim HJ; Lotan D; Myers J; Lotan R
    Cancer Res; 2008 Jun; 68(11):4416-23. PubMed ID: 18519704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.
    Anderson CP; Tsai JM; Meek WE; Liu RM; Tang Y; Forman HJ; Reynolds CP
    Exp Cell Res; 1999 Jan; 246(1):183-92. PubMed ID: 9882527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion.
    Jin M; Yaung J; Kannan R; He S; Ryan SJ; Hinton DR
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4311-9. PubMed ID: 16249513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
    Appierto V; Tiberio P; Villani MG; Cavadini E; Formelli F
    Carcinogenesis; 2009 May; 30(5):824-31. PubMed ID: 19325135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells.
    Lee HM; Kim DH; Lee HL; Cha B; Kang DH; Jeong YI
    Arch Pharm Res; 2019 Nov; 42(11):990-999. PubMed ID: 31482490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.